Status:
UNKNOWN
Evaluation of the STANDARD G6PD Rapid Test for Assaying the Enzymatic Activity of G6PD in French Guiana
Lead Sponsor:
Institut Pasteur
Collaborating Sponsors:
Institut Pasteur de la Guyane
Centre Hospitalier Andrée Rosemon de Cayenne
Conditions:
Paludism
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
In French Guiana, malaria is endemic and two species predominate: P. falciparum and P. vivax. The treatments against Plasmodium vivax malaria are: nivaquine for 3 days against circulating blood parasi...
Detailed Description
This is a interventional,prospective, multicenter, cross-sectional and comparative study. To achieve this study, the following will be done: * Selection of subjects according to their G6PD activity ...
Eligibility Criteria
Inclusion
- People with a known level of G6PD activity.
- People or their legal representatives who have received information on the research and have signed a written consent to participate in the study
- People aged over 18 for the "intermediate" and "normal" categories,
- People aged two years and over for the "severe deficit" category.
Exclusion
- People with an unknown level of G6PD activity,
- People or their legal representatives who refused to participate in the study,
- People aged under 18 for the intermediate and normal categories,
- Children under 2 years old for the "severe deficit" category,
- People with a hemoglobin level below 11g / dL for men and 10g / dL for women and children.
- People who received a transfusion less than 4 months before the proposal to participate in the G6PD study
Key Trial Info
Start Date :
May 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04698980
Start Date
May 5 2021
End Date
December 31 2022
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Pasteur de la Guyane
Cayenne, French Guiana